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Cellular retinoid binding protein s are thought to be in-
volved in the molecular action of retinoids, a family of 
compounds success full y used in the trea tm ent of psori asis. 
Therefore, both ce llular retino l (CRBP)- and retinoic acid 
(CRABP)-bindin g proteins were analyzed in psoriatic skin. 
Three fa cts emerged from our study: (a) both CRABP and 
CRBP are detectable in the skii1 of pso riatic patients; (b) 
qualitatively, they both appear similar to the correspondin g 
proteins of norm al hum an skin, in terms of their eiution 
profile and apparent Kr1; and (c) quantitatively, on ly C RABP 
S ynth eti c vitam in A derivatives, especiall y those with a carbo xy lic g roup, arc now w idely used for th e systemi c treatment cif se veral dermatoses in cludin g pso riasis . . Pso-n as ls 1s charac tcn zed by a nonneoplasti c hypcrprolifer-at ive state of areas of the ep id crh1is wh ich have been 
clearly shown to be responsive to system ic admini st ration of sy n-
theti c retinoids containin g a ca rboxy l 111 . The mode of action of 
these co mpounds at the molecular level, however, especiall y in 
the skin , is not yet fully understood. A number of tissues in 
hum ans and various other species contain 2 distinct so luble in-
tracellul ar proteins with binding specifi city fo r either retino l (cel-
lular retinol-bindin g protein, C HBP) or retinoic acid (cellular 
retinoic acid-binding pro tein , CH ABP) [2j. There is evidence that 
C HABP and C RBP allow the specifi c tran sfer o f their li gands, 
rctinoic acid and retin ol, respectively, to nu clea r chromatin (3j. 
Further interest in these intracellular retinoid-bindin g pro teins has 
been stimulated by obse rvations sugges tin g a link between their 
ability to bind vario us ret in oids and their biologic activities 13-5]. 
Several laboratories arc ac tively investiga tin g the re lation between 
C RABP and cance r and between C HABP and the anticarcino-
gcni c activity of retinoids [2,6-8]. 
We have recently found [9] that CRBP was present in equal 
concentrations in both normal hum an dermis and epidermis , 
w hereas CRABP was mainly located in the epidermis; this sug-
ges ted that compared to dermis the epidermis may be a prefer-
ential target for rctinoids possess in g a ca rboxyl. 
We now report that both CRABP and C RBP could also be 
detected in psoriatic skin, but only CRABP is significantly ele-
vated in pso riatic plaques as co mpared to either nonlesional pso-
riati c skin o r normal controls. 
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was found to be 3 times higher in psoriatic plaques as 
co nlpared to either nonlesio nal skin of psoriatic patients or 
the skin of normal subjects. Since psoriatic plaques are 
parti cularl y responsive to system ic retinoids, specifica ll y to 
retinoi c acid ana logues, our results sugges t for the fir st time 
a link between the levels ofCRABP and the responsiveness 
of a nonneoplastic hyperp roliferative tissue to sys temic 
administration of retinoids in the human. J il11lest Dermatol 
86:42-45, 1986 
MATEHlALS AND METHOD S 
The [ 11 , 12-3H]ail-trat1s-retinoi c acid (30 C i/ m mol) used was a gi ft 
fro m F. Hoffmann-La Roche (Basel, Switzerland). [15-3H]al1-
trat15-Hctinol (14. 3 Ci/mmol) and Diofluor were purchased from 
NEN (F.R. G.) . all-trans-Retin oic acid and all-trmu -rctinol were 
obtained fro m Sig m a. Purity was checked by hi gh-performance 
liquid chro m atography. Sep hadcx G75 superfine , Blue Dextran 
2000, and ribonuclease A were purchased from Pharm acia (Upps-
ala, Sweden). All rctinoids were sto red at - 20°C in ethano l con-
taining 0.02% butylated hyd roxytoluenc. All o ther chemica ls were 
of ana lyt ica l g rade. Wate r was do ubl e-distilled. The homogenizer 
was obtained fro m Kincmatica (Lu cern e, Switzerland). The ra-
dioac tivity was co unted in a Beckman, LS- '1800 liquid scintillation 
spcctro ph otomcrcr. 
Patients and Controls Kcratomized (keratom e set at 180 /Lill) 
norm al skin sa mples were obta ined from breas t o r abdomen ol 
health y women undergoin g plasti c surgery. Eig hteen adult pso-
ri atic patients, 12 m ales and 6 females, aged 35-77 (mean 49) 
years, bein g w ithout any treatm ent for at leas t 1 month, gav 
th eir informed consent fo r keratom e skin samplin g. Samples were 
obtained either from involved stable plaques located on the thigh 
(9 cases), abdomen (2 cases), or buttocks (8 cases), with keratome 
set at 280 /Lm, o r from noninvolvcd sk in located on the anterior 
aspect of th e thi gh (5 c&ses), with keratom e set at 180 /LlTI . Pre-
liminary determinations have shown that there was little variation 
i11 th e skin levels of both C HABP and C HBP between breast. 
thi gh, and abdomen in no rm al and pso riatic subjects . 
Preparation of the Skin Supernatants Aliquots (15-20 m g' 
of lyophi lized skin tissue s:1 mples were homogen ized in 800 ~ 
of ex traction buffer (Tris-HC I 50 111M, N aCl 25 mM , EDTA 25 
mM , pH 7. 5) usin g a tissue homogen izer. Tissue supernatanll 
were obtained after centrifu ga tion at 100,000 g for 60 min at 4°( 
apd were immediately used fo r the vario us assays. Protein co ntent 
11 0] was determined usin g bovine serum albumin as standard . 
Incubation and Gel Filtration Assay Binding proteins w en 
quantitated by in cubation of sa mples w ith [11 , 12-3 H] all-tram· 
retinoi c acid 50 nM or (15-3H]all-tral'ls-retinol 50 nM followed b1 
gel filtration as previously described (9]. Two hundred-fold exce 
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un labeled li ga nd was added for binding competition studies. The 
sa mples were then sub mitted to gel filtration o n a Sep hadex G75 
(0.8 x 15 em) co lumn eq uilibrated with th e ext rac ti on bu ffe r 
con taining 10 m M N aN 3 and ca librated with ribon uclease A. Frac-
tions of 300 fLl were collected and their rad ioactivi ty assessed in 
a liquid scintil lation co unte r usin g 8 ml BioAuor per fra ction. 
Charcoal-Dextran Assay A charcoa l-dextra n assay J11J was 
used to quantitate th e bind in g proteins. This method was used 
beca use the no nspecifi c J-'H [ret in o id bindin g in the skin super-
natants was low (Fig 1 ), the skin sa m pies were small in size, and 
for each sample the measurem ents co uld be performed in dup li-
cate. The tiss ue supern atants we re filtered through g lass fi lters to 
remove so m e of the lipids. T he incubation of the sa mples with 
SO nM [3!-IJreti no id in the presence o r absence of 200-fo ld excess 
un labeled li ga nd was ca rri ed o ut at 4°C fo r 16 h. Subsequ entl y . 
300 fLI cold extractio n buffer was added to th e sa mples and 350 
fLI of the resultin g solut ion was mi xed w ith 400 fLl charcoa l-
dex tran suspension (0.8% charcoa l, 0.08% dextran T70, 0.25 M 
sucrose 1 m M EDTA in 0 .01 M Tris-HCl, pH 7.5). After 15 min 
the tub~s v,;e re centrifu gated at 10,000 .~ for 15 min . Supernatants 
(400 fLl ) we re co unted fo r radioactivity as described above. 
Binding Criteria We ha ve found linearity of retin o id-binding 
activities vs protein concentrati on of supernatants in the range of 
0.6-1 .4 IT)g protein per mi. Therefore, all the determmanons were 
done in this range. Co mpetitive di splacements were perfo rm ed 
ro establi sh specificity of the ret inoid bindin g : each tissue super-
natant was in cubated w ith radi oactive reti no l or retino1c aCid In 
the presen ce or absence of a 200-fo ld excess of the unlabeled 
compound [9, 11]. C RABP showed a hig h binding specifi city and 
[3H]retino ic acid coul d no t be displaced by excess of ret ino l (never 
more than 15%). In contra st, the C i<..BP peaks showed, in a few 
sa mples, a hi g her disp la ce m ent b y an excess of rctin o ic acid J9, 11] . 
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Figure 1. Gel fi ltration analysis on Scphadcx G75 of norma l human skin 
(A) and psoriatic plaques (B) extracts in presence of 50 J.L M [3H Jretinoic 
acid (e-o). with an excess of 200-fold unlabeled retinoic acid (•- • ) or 
retinol (.A. - .A. ). Nonlcsional psoriatic skin shows exactl y the sa me profi le 
as the normal sk in (not shown). Note that the sca le for normal skin is 
smaller than that for psoriatic pl aques. 
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Correlation of Gel Filtration with Charcoal-Dextran Gel 
fi ltrat io n and charcoa l-dextra n determinations closely co rrelated 
(1· = 0 . 914, p < 0.00 I , n = 13) indi ca tin g that J·' HJrcti nol and 
J' HJreti no ic acid total binding activ ities co rresponded , res pec-
tivel y, w ith C RBP and CRABP binding sites. M o reove r, the 
ratios of CR ABP/ CR.B P did not d iffer signifi cantl y (p < 0. 173) 
w hen data o btained by these two methods were compared. 
Assays for Serum Retinol-Binding Protein Poss ible co p-
tamination of the skin extracts by tl1e se rum retinol-binding pro-
tein (s RBP), w hi ch ca n bind both retin o l and ret ino ic acid in vitro 
JI 2 J, was checked by affi nity co lumn . Rad ioactive peaks ofCR.BP 
elu ted ti·om Sephadex G75 co lumn vvere co mbined and ap plied 
to a co lumn of transth yretin coupled to Sepharosc !1 3]. Most of 
J :~ HJreti no l was fo und to be immed iate ly eluted off w ith no af-
finit y for transthyrctin , exclqdin g the possibi li ty that J.lH]rctin o l-
sRBP was in vo lved J1 4]. In fac t, sRBP was detected onl y in tra ce 
am oun ts in pso riatic plaques, and was usuall y und etectable in 
norm al as wel l as in no nin volved psoriatic skin as previous ly 
repo rted 111, 14]. 
Saturation Experiments Sa turatio n ex periments were ca rried 
out to co mpare the m ax imum binding ca pacities and the apparent 
dissociation consta nts (Kd) of tissue supernatants from normal 
skin and pso ri ati c plaques. Eq uilibrium binding affinities were 
perfor m ed by runnin g binding assays with in creas in g amo unts 
of J-' H [retinol (5-800 nM) and J3 H ]reti noic acid (5-1 000 n M) in 
th e presence and absence of a 200-fold excess of the correspondin g 
unbbelcd li gand. Aliquots of diffe rent in cubatioi1 mixtures were 
co unted for rad ioactivity directly to determine the respective tota l 
J3H]retin oids concentrat ion , whereas ~h e rem ainin g sa mples were 
subj ected to the charcoa l-dextran assay. 
Data Analysis Linear regressio n (Sca ttergramm) and paired and 
unpaired Wilcoxon tests were done usin g program s fro m the 
SPSS Computer Progra m , N o rth wes tern University , Eva nston , 
Ill inoi s. Sca tchard tests were done usin g the Scatfit program 
of V. Faden and D. i<.odba nd . National Inst itutes of Health 
Bethesda, Maryland. ' 
RESULTS 
The eluti on pro fil es of th e supern ata nts of normal and les io nal 
pso riati c hum an skin in cubated with J·'HJretin o ic acid arc shown 
in Fi g I A ,B . The peak w hich eluted a bit ea rlier than ribo nu clease 
A was due to the presence of C RA.BP . It was abolished w ith a 
200-fo ld excess of rctinoic acid but was unaffected by the sa m e 
excess of retin o l. The elutio n profiles of supern atants from pso-
ri atic plaques in cubated w ith [3 1-1 !retino l in the presence o r absence 
of excess retinql o r retin oic acid were similar to those we h ave 
recentl y described for no rm al hum an skin J9, 11] . O n the other 
hand , th e eluti on profile in Fig 1 B indi ca tes hi gher concentrat io n 
of C I<.ABP present in the psoriatic skin. 
Scatchard analyses o n an indi vidual bas is arc presented in Table 
I. These figures were derived J! S] from spndard Scatcha rd plot 
an alys is usin g computer plotting of nonlin ea r regressio n curves 
with correct ion fo r nonspecifi c binding. 
Results in Table I show the apparent dissociation cons tants of 
no rm al and pso ri atic (lcsional) hum an sk in . T hese values arc ve ry 
simibr and fa ll well w ithin the range for norma l hum an epidermis 
and other hum an tissues 19, 16-18]. The affin ity of retin o l for 
CR.BP seem ed hi gher than retin oic acid fo r CR ABP . M aximum 
bindin g capaciti es for C i<..BP did not differ from no rm al w hen 
co mpared to lesio nal psoriatic skin sa mpl es in contrast to C I<.ABP 
w hi ch was 4 times hi gher in th e pso riatic skin. 
Fig 2 shows the levels of C RA BP and CRBP in lcs ional and 
nonlcsional psoriati c and no rm al skin sa mpl es as m easured by 
charcoa l-dextran technique. Normal and nonlesional psoriatic skin 
showed eq ui va lent amounts of C RA.BP (2.38 :!.: 0.24 SEM and 
2.35 :!.: 0. 17 SEM pmo l X m g - 1) w hereas in pso riatic plaques 
C I<.ABP was 3 tim es hi gher (7.8 1 :!.: 1. 76 SEM , p < 0.0005). 
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Table I. Binding C apacities and Apparent Dissociation Constants o f C RABP and C RBP 
C RABP CHI3l' 
No. K, (n M) Q (pmol/mg protein) No. K, (nM ) Q (pmol/mg protein) 
N ormal 
Psoriasis 
3 
3 
361 ± 134 
484 ± 289 
26.5 ± 4.3 
11 2.2±48.7 
4 
2 
60.2 ± 25.2 
63.8 ± 38.2 
4.0 ± 2.0 
4.82 ± 1.7 
Binding ca pacities (Q) and appa rent di ssociatio n constants (K,) of C RA 131' and C Rill' we re measured by charcoal-dex tran method and calculated as descri bed in rcxt. 
No rmal, skin sa mples fro m no rmal hum:m subj ects; psorias is, sampl es fro m psoriati c pla ques; ± SEM . 
C RBP level s w ere practi call y the same in all sa mples studi ed . It 
w as possible to an alyze C RABP and C RBP binding sites in non-
saturatin g conditions since the K., have been determined and were 
found to be similar. 
DI SCUSSIO N 
Three fac ts em erged from our res ults concernin g th e skin of pso-
ri ati c patients: (a) both C RABP and C RBP arc detectable ; (b) they 
bo th appear qualitati ve ly to be similar (elution pro files and ap-
parent Kd) to proteins previously fo und in no rmal hum an skin 
and epidermis [9, 11 ]; and (c) onl y C RABP w as fo und to be sig-
nificantl y elevated in pso riatic plagues as compared to nonlesion al 
skin of pso riatic patients and to the skin o f normal subj ects . These 
findin gs arc no t "due to a difference in skin sa mplin g as C RBP 
was found no t to be elevated. 
In this study we have used ·a charcoal-dex tran technique w hi ch 
is more sensiti ve than the g el filtration or sucrose g radient anal-
ys is. This explains w h y w e found hig her m aximum binding ca-
paciti es for both C RAB P and C RBP with the charcoal-dextran 
technique a ~ compared to our previous fmdin g usin g gel fdtration 
analys is of epidermal extracts [9). H ow ever, the charcoal-d extran 
technique should be rega rded as a quantitative, not qu alitative 
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Figure 2. CRAI3P and CRB P in norm al (n = 8), unin volved (n = 8) , 
and plaques of psoriatic (n = 13) skin . Values were measured by charcoal-
s\cxtran method with 50 nM of 13H]retinoids in nonsaturatin g conditions 
(sec details in the text) . 
one. There fo re, w e also anal yzed ce llula r retino id bindin g pro teins 
by gel filtration, whi ch also dem o nstrated an in crease o f C HA BP 
in pso ri ati c plaques . 
O ur fin d in gs suggest that C RABP m ay pla y a ro le in th e mech-
anism o f sensiti vity of human skin to adminis trati on of systemic 
rc tin o ids hav in g a ca rboxyli c g roup. Whether the levels o f a bind-
in g pro tein co rrelate with the m odulatin g effects o f rctin oids re-
mains to be es tablished 111. We beli eve th at our findin gs suggcsl 
th at such a correlati on mi ght ex ist in humans. In fa ct, when 
pso ri ati c patients arc g iven sys temi c retin o ids, th e plaques show 
m o re sig ns, bo th clini call y and biologicall y, o f retin oid effect than 
the nonlesional skin . C lini call y, psoriati c plaques show a high 
degree of scaling and decreased infiltration \1 9,201. Si gni f1can1 
biologic m odifi cations arc also obser ved durin g retinoid therapy 
in les ional co mpared to nonlesional pso riati c skin such as: decrease 
o f epiderm al ON A sy nth es is [21] , decrease of putrescine and oi 
the spermidin e to spermiqc rati o \22 1, as w ell as a decline in 
concentrations of arachidonic acid and 12-L-h ydroxy- 5,8, 10,1 4-
cicosatctracnoic acid [20 ). O ne can hypo thes ize th en th at e levated 
C RABP levels in pso riatic pl aqu es are in volved in the disti nct 
res ponse o f th ese plaques to sys temi c retinoid therap y . This w ould 
be the first sugges tion that in humans a link exists between C HABP 
and th e res ponsiveness of a hyperproli fc rati vc nonneoplasti c dis-
case to retinoids. Work is presentl y in progress to correlate til<' 
degree o f res pon siveness o f pso ri ati c pl aques to rctin o ids and the 
level o f C RABP in th ese parti cula r lesions as w ell as th e ir mod-
ifi ca ti o n und er such treatment. 
That retin oic acid , and no t retin ol binding s ites, w as elevated 
sugges ts an independ ent regulati on of bo th pro teins in psoriatiC 
pl aques ; such an independent regulatio n has alread y been o bserved 
in o ther tiss ues and is rele vant to th e sugges ti o n th at th e m o lecular 
ro les o f retin ol and retin oic acid arc no t identi ca l /2J. There is l 
strikin g correlati on between th e ability o f synth eti c analogues ol 
rctin o ic acid to interact w ith C RA B P and th eir bio log ic acti vit) 
[4,5,23]. The availability of a free carbo xyl g roup at th e c,, 
position o f such rctinoids is necessary fo r their ability to bind to 
C RABP [4,5] . Consequentl y if C RABP is in volv ed in the ac tion 
o f syntheti c an alogues o f retino ic acid , such co mpo unds w ith a 
blocked C 1s ca rboxy l group must first be hydro ly zed to the fr 
acid fo rm Jn o rder to beco m e bio logicall y activ e [2]. It is inter· 
es tin g therefo re th at ctretin ate , used in the treatm ent o f psoriasis. 
has an eth yl es ter group at the C 1s position ; it has however be~!' 
fo und th at ctretin ate appears to be a prodru g and is rapidl y hy· 
dro li zed [24] into the fr ee acid fo rm etrctin whi ch is clini cal!\ 
acti ve [25]. · 
N o elevati on of C RABP w as detected in th e noninvo lvcd pso-
riati c skin ; this is of interest sin ce several abno rm aliti es exist ir 
the apparently no rm al skin o f pso ri atic patients [26]. It appea[) 
therefo re that the in creased level o f C RABP is indeed associatt' ' 
with th e development o f the full hyperplasti c lesio n rather thar 
bein g a new ly fo und abn orm ality o f the w ho le pso ri ati c skin . 
In creased C RABP in pso ri ati c plaqu es ma y indi cate either ar 
in crease in the number of (epidermal) cell s that norm ally contair 
this pro tein o r an alte red ex pressio n o f the gene coding fo r th~ 
pro tein . Elevated C RABP has been reported in neoplas ti c, fetal 
and regeneratin g tiss ues [2]. Our findin gs ma y n.:Acct either thi 
in creased proliferation or altered differenti ation o f the psoriaci, 
plaque epidermis. Preliminary o bservatio ns in o ther nonc m cer' 
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ous proliferative sk in disorders w here CRAI3 P was not found to 
be constantly elevated suggest that factors other than mcreased 
epidermal turnover arc invo lved J27 J. 
Note: C HABP was also increased when ca lcu lated on DNA 
basis. 
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